Skip to main content
Clinical Trials/IRCT2016052828127N1
IRCT2016052828127N1CompletedPhase 2

Study of Evaluation of the therapeutic effects of Hab Shabyar on Intraocular pressure in patients with open-angle glaucoma: A double-blind clinical trial

Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 70 years (—)
Sex
All

Inclusion Criteria

  • age between 20-70 years; patients with open-angle glaucoma with IOP 11-21 mm Hg; patients with Informed consent.
  • Exclusion criteria: patients that who have angle-closure glaucoma; Crohn's and Colitis Disease; hemorrhoids; use of systemic drugs to interfere with the IOP and pregnant women.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences

Similar Trials